Yanni Souroutzidis
Stock Analyst at Cantor Fitzgerald
(1.41)
# 3,512
Out of 4,476 analysts
4
Total ratings
50%
Success rate
-1.7%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Yanni Souroutzidis
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TRDA Entrada Therapeutics | Initiated Coverage: Buy | n/a | $7.72 | - | 1 | Apr 1, 2026 | |
| TSX: MSCL Satellos Bioscience Inc. | Initiated Coverage: Buy | n/a | $10.91 | - | 1 | Mar 11, 2026 | |
| KPTI Karyopharm Therapeutics | Maintained: Buy | n/a | $9.60 | - | 2 | Mar 6, 2026 |
Entrada Therapeutics
Apr 1, 2026
Initiated Coverage: Buy
Price Target: n/a
Current: $7.72
Upside: -
Satellos Bioscience Inc.
Mar 11, 2026
Initiated Coverage: Buy
Price Target: n/a
Current: $10.91
Upside: -
Karyopharm Therapeutics
Mar 6, 2026
Maintained: Buy
Price Target: n/a
Current: $9.60
Upside: -